Product details

The Ultimate Clinical Workstation
The Dr. Pen A11 is not just a microneedling pen; it is a self-contained clinical workstation designed for severe skin remodeling. Traditional devices fail when battery torque drops, causing needles to drag and tear the epidermis. The A11’s pro-grade motor guarantees zero torque-loss, ensuring that a 1.5mm setting delivers exactly 1.5mm of sustained mechanical trauma.

Aggressive Fibrosis & Atrophic Scarring
By inflicting calculated dermal micro-wounds, the A11 forces the body’s natural fibrosis cascade into overdrive. This mechanism aggressively accelerates Type I Collagen Synthesis. This influx of new structural proteins is clinically proven to elevate and smooth severe atrophic acne pits, deep surgical scars, and thick-tissue stretch marks from the inside out.

Inductive Base: Auto-secures the device vertically during pauses, eliminating surface cross-contamination.
Dermal Mapping Motor: Maintains absolute torque stability at all depths (0.0mm - 2.5mm).
EO Sterilization: Every cartridge undergoes strict Ethylene Oxide gas sterilization to eliminate
Load video: Load video:

Clinical Protocol: A11 Workstation Execution

Watch the official clinical demonstration of the Dr. Pen A11, highlighting the use of the inductive sterile base during mid-session pauses and proper dermal mapping techniques.

The Physics of Inductive Sterility

Placing a device on a non-sterile table mid-session is the leading cause of bacterial cross-contamination. The A11 eliminates this critical flaw with its smart Inductive Base . When paused, the device rests vertically, keeping open micro-needles completely isolated from surface pathogens.

FDA-Registered Clinical Safety

Severe skin remodeling requires strict safety protocols. The Dr. Pen A11 is manufactured in an FDA-Registered Facility, holds full CE Certification, and utilizes EO Sterilizedcartridges to provide the ultimate sterile environment for dermal mapping.

Clinical Protocol

Sterilization Verification

Unpack a single-use EO Sterilized cartridge.

Base Setup

Plug in the Inductive Base. Always return the A11 to the base when pausing. Never lay it flat on a table.

Depth Calibration

Use 0.25mm - 0.5mm for transdermal serum delivery. Use 1.0mm - 2.5mm strictly for structural scar remodeling.

Wound Healing

Erythema is required. Keep the skin sterile for 48 hours.

Technical Specifications

Parameter Specification

E-E-A-T Certifications

FDA-Registered Facility, CE, RoHS

Sterilization Protocol

EO (Ethylene Oxide) Gas Sterilization

Workstation Architecture

Smart Inductive Base + Wireless Device

Motor Action

Pro-Grade Dermal Mapping (Zero Torque-Loss)

Depth Calibration

0.0mm - 2.5mm

✈️ Free Global Shipping

🛡️ 1-Year Warranty

FAQs

Please read our FAQs page to find out more.

Q1: Why is the Inductive Base critical for clinical safety?

A: Resting a device on a table mid-session invites pathogens into the cartridge. The A11’s base holds the device vertically, ensuring needles never touch unsterilized surfaces.

Q2: What is Dermal Mapping and how does the A11 achieve it?

A: Dermal mapping maintains exact needle penetration depth regardless of skin resistance. The A11’s pro-grade motor ensures that a 2.0mm setting delivers exactly 2.0mm of penetration without lateral drag.

Q3: Can the A11 treat deep, thick-tissue stretch marks?

A: Yes. Its sustained motor output and 2.5mm depth calibration induce the aggressive fibrosis required to remodel thick tissue.

Q4: Does the Inductive Base charge the device while resting?

A: Yes. The base acts as both a sterile resting station and an inductive charging dock, ensuring the pro-grade motor never loses torque.

Q5: Are the cartridges backwards compatible with older models?

A: No. The A11 utilizes a specific bayonet locking mechanism designed to handle the high torque of its pro-grade motor.

Q6: What is the expected downtime after a 1.5mm session?

A: Expect visible erythema (redness) resembling a sunburn for 24-48 hours. Petechiae (pinpoint bleeding) is the correct biological response for triggering Type I Collagen